AAM: Generics and biosimilars saved U.S. health system $496 billion in 2025
Generics and biosimilars represented 89% of U.S. prescriptions but only 12% of prescription drug spending in 2025, according to AAM.
Generics and biosimilars represented 89% of U.S. prescriptions but only 12% of prescription drug spending in 2025, according to AAM.
Researchers found an mRNA flu vaccine produces broader antibodies than conventional ones, offering clues for more lasting influenza protection.
The Orchards Elementary project is part of CVS Health’s multi-year effort to expand access to community recreation through soccer.
Customers can now manage prescriptions, check costs and connect with pharmacists entirely in Spanish.
Endocrinologist Dr. Rocio Salas-Whalen leads a new MasterClass course designed to help patients better understand GLP-1 therapy.
Emarsys finds that fragmented data is preventing many brands from fully deploying AI across customer engagement.
The FTC and 22 states allege Amazon secretly increased advertising prices while misleading brands and sellers about how its ad auctions operated.
NCPA warns that independent pharmacies could be required to provide competitively sensitive acquisition-cost information to vertically integrated PBMs.
The deal would significantly expand the company’s presence across supplements, sports nutrition, weight management, beauty, and longevity wellness.
Patients booking care through Solv can now see Amazon Pharmacy same-day and next-day prescription delivery availability before their appointment.
A U.S. News & World Report survey shows experts prefer exercise, nutrition, and sleep over trendy longevity fixes, highlighting opportunities in supplements, GLP-1s, and women’s health.
New research for the Neighbourhood Pharmacy Association of Canada shows community pharmacies support over 273,000 jobs and add nearly $23 billion yearly to Canada’s economy.
Federal efforts to increase PBM transparency are putting greater attention on whether changes to rebates and compensation ultimately lower pharmacy costs.
Scott Melville will conclude a 16-year tenure during which CHPA expanded its reach across the broader self-care industry.
The Certified Group acquisition will add 31 North American laboratories and expand testing services for OTC products, dietary supplements, and cosmetics.
TSE 2026 in Boston showed an industry aiming to expand pharmacy’s community role in healthcare amidst reimbursement pressures, technological shifts, and retail changes.